Correlation Between Caribou Biosciences and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Sana Biotechnology, you can compare the effects of market volatilities on Caribou Biosciences and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Sana Biotechnology.
Diversification Opportunities for Caribou Biosciences and Sana Biotechnology
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Caribou and Sana is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Sana Biotechnology
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Sana Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 4.99 times less risky than Sana Biotechnology. The stock trades about -0.18 of its potential returns per unit of risk. The Sana Biotechnology is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 161.00 in Sana Biotechnology on December 28, 2024 and sell it today you would earn a total of 10.00 from holding Sana Biotechnology or generate 6.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Sana Biotechnology
Performance |
Timeline |
Caribou Biosciences |
Sana Biotechnology |
Caribou Biosciences and Sana Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Sana Biotechnology
The main advantage of trading using opposite Caribou Biosciences and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |